Autologous Muscle Stem Cell Therapy for Treatment of Congenital Urinary Incontinence in Epispadias Patients

NCT04729582 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Urinary Incontinence
Epispadias, Male

Interventions

BIOLOGICAL: Primary human muscle stem cells (Satori-01)
OTHER: Placebo

Sponsor

Simone Spuler, MD

Collaborators

[object Object]